Selected research
Market Outlook & Growth Opportunities
Global Injectable Packaging Market Outlook and Growth Opportunities 2026
Market perspective
The global Injectable Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Injectable Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Injectable Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Injectable Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Injectable Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Injectable Packaging market include Schott AG, Gerresheimer AG, West Pharmaceutical Services, Stevanato Group, Becton, Dickinson and Company, Catalent, SGD Pharma, Nipro Corporation and Datwyler Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Injectable Packaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Injectable Packaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Injectable Packaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Injectable Packaging market.
Injectable Packaging Segment by Company
Schott AG
Gerresheimer AG
West Pharmaceutical Services
Stevanato Group
Becton, Dickinson and Company
Catalent
SGD Pharma
Nipro Corporation
Datwyler Group
Stevanato Group's Ompi
SGD Pharma's Gerresheimer
Injectable Packaging Segment by Type
Vial
Injection
Cartridge
Other
Injectable Packaging Segment by Application
Hospitals and Medical Facilities
Pharmaceutical Company
Other
Injectable Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Injectable Packaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Injectable Packaging key companies, revenue, market share, and recent developments.
3. To split the Injectable Packaging breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Injectable Packaging market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Injectable Packaging significant trends, drivers, influence factors in global and regions.
6. To analyze Injectable Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injectable Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Injectable Packaging industry.
Chapter 3: Detailed analysis of Injectable Packaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Injectable Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Injectable Packaging in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Vial
- Injection
- Cartridge
- Other
Applications
- Hospitals and Medical Facilities
- Pharmaceutical Company
- Other
Companies covered
- Schott AG
- Gerresheimer AG
- West Pharmaceutical Services
- Stevanato Group
- Becton, Dickinson and Company
- Catalent
- SGD Pharma
- Nipro Corporation
- Datwyler Group
- Stevanato Group's Ompi
- SGD Pharma's Gerresheimer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Injectable Packaging Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Injectable Packaging Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Injectable Packaging Market Dynamics
- 2.1 Injectable Packaging Industry Trends
- 2.2 Injectable Packaging Industry Drivers
- 2.3 Injectable Packaging Industry Opportunities and Challenges
- 2.4 Injectable Packaging Industry Restraints
3 Injectable Packaging Market by Company
- 3.1 Global Injectable Packaging Company Revenue Ranking in 2025
- 3.2 Global Injectable Packaging Revenue by Company (2021-2026)
- 3.3 Global Injectable Packaging Company Ranking (2024-2026)
- 3.4 Global Injectable Packaging Company Manufacturing Base and Headquarters
- 3.5 Global Injectable Packaging Company Product Type and Application
- 3.6 Global Injectable Packaging Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Injectable Packaging Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Injectable Packaging Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Injectable Packaging Market by Type
- 4.1 Injectable Packaging Type Introduction
- 4.1.1 Vial
- 4.1.2 Injection
- 4.1.3 Cartridge
- 4.1.4 Other
- 4.2 Global Injectable Packaging Sales Value by Type
- 4.2.1 Global Injectable Packaging Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Injectable Packaging Sales Value by Type (2021-2032)
- 4.2.3 Global Injectable Packaging Sales Value Share by Type (2021-2032)
5 Injectable Packaging Market by Application
- 5.1 Injectable Packaging Application Introduction
- 5.1.1 Hospitals and Medical Facilities
- 5.1.2 Pharmaceutical Company
- 5.1.3 Other
- 5.2 Global Injectable Packaging Sales Value by Application
- 5.2.1 Global Injectable Packaging Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Injectable Packaging Sales Value by Application (2021-2032)
- 5.2.3 Global Injectable Packaging Sales Value Share by Application (2021-2032)
6 Injectable Packaging Regional Value Analysis
- 6.1 Global Injectable Packaging Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Injectable Packaging Sales Value by Region (2021-2032)
- 6.2.1 Global Injectable Packaging Sales Value by Region: 2021-2026
- 6.2.2 Global Injectable Packaging Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Injectable Packaging Sales Value (2021-2032)
- 6.3.2 North America Injectable Packaging Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Injectable Packaging Sales Value (2021-2032)
- 6.4.2 Europe Injectable Packaging Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Injectable Packaging Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Injectable Packaging Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Injectable Packaging Sales Value (2021-2032)
- 6.6.2 South America Injectable Packaging Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Injectable Packaging Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Injectable Packaging Sales Value Share by Country, 2025 VS 2032
7 Injectable Packaging Country-level Value Analysis
- 7.1 Global Injectable Packaging Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Injectable Packaging Sales Value by Country (2021-2032)
- 7.2.1 Global Injectable Packaging Sales Value by Country (2021-2026)
- 7.2.2 Global Injectable Packaging Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.7.2 France Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.14.2 China Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.17.2 India Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Injectable Packaging Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Injectable Packaging Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Injectable Packaging Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Injectable Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Schott AG
- 8.1.1 Schott AG Company Information
- 8.1.2 Schott AG Business Overview
- 8.1.3 Schott AG Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.1.4 Schott AG Injectable Packaging Product Portfolio
- 8.1.5 Schott AG Recent Developments
- 8.2 Gerresheimer AG
- 8.2.1 Gerresheimer AG Company Information
- 8.2.2 Gerresheimer AG Business Overview
- 8.2.3 Gerresheimer AG Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.2.4 Gerresheimer AG Injectable Packaging Product Portfolio
- 8.2.5 Gerresheimer AG Recent Developments
- 8.3 West Pharmaceutical Services
- 8.3.1 West Pharmaceutical Services Company Information
- 8.3.2 West Pharmaceutical Services Business Overview
- 8.3.3 West Pharmaceutical Services Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.3.4 West Pharmaceutical Services Injectable Packaging Product Portfolio
- 8.3.5 West Pharmaceutical Services Recent Developments
- 8.4 Stevanato Group
- 8.4.1 Stevanato Group Company Information
- 8.4.2 Stevanato Group Business Overview
- 8.4.3 Stevanato Group Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.4.4 Stevanato Group Injectable Packaging Product Portfolio
- 8.4.5 Stevanato Group Recent Developments
- 8.5 Becton, Dickinson and Company
- 8.5.1 Becton, Dickinson and Company Company Information
- 8.5.2 Becton, Dickinson and Company Business Overview
- 8.5.3 Becton, Dickinson and Company Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.5.4 Becton, Dickinson and Company Injectable Packaging Product Portfolio
- 8.5.5 Becton, Dickinson and Company Recent Developments
- 8.6 Catalent
- 8.6.1 Catalent Company Information
- 8.6.2 Catalent Business Overview
- 8.6.3 Catalent Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.6.4 Catalent Injectable Packaging Product Portfolio
- 8.6.5 Catalent Recent Developments
- 8.7 SGD Pharma
- 8.7.1 SGD Pharma Company Information
- 8.7.2 SGD Pharma Business Overview
- 8.7.3 SGD Pharma Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.7.4 SGD Pharma Injectable Packaging Product Portfolio
- 8.7.5 SGD Pharma Recent Developments
- 8.8 Nipro Corporation
- 8.8.1 Nipro Corporation Company Information
- 8.8.2 Nipro Corporation Business Overview
- 8.8.3 Nipro Corporation Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.8.4 Nipro Corporation Injectable Packaging Product Portfolio
- 8.8.5 Nipro Corporation Recent Developments
- 8.9 Datwyler Group
- 8.9.1 Datwyler Group Company Information
- 8.9.2 Datwyler Group Business Overview
- 8.9.3 Datwyler Group Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.9.4 Datwyler Group Injectable Packaging Product Portfolio
- 8.9.5 Datwyler Group Recent Developments
- 8.10 Stevanato Group's Ompi
- 8.10.1 Stevanato Group's Ompi Company Information
- 8.10.2 Stevanato Group's Ompi Business Overview
- 8.10.3 Stevanato Group's Ompi Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.10.4 Stevanato Group's Ompi Injectable Packaging Product Portfolio
- 8.10.5 Stevanato Group's Ompi Recent Developments
- 8.11 SGD Pharma's Gerresheimer
- 8.11.1 SGD Pharma's Gerresheimer Company Information
- 8.11.2 SGD Pharma's Gerresheimer Business Overview
- 8.11.3 SGD Pharma's Gerresheimer Injectable Packaging Revenue and Gross Margin (2021-2026)
- 8.11.4 SGD Pharma's Gerresheimer Injectable Packaging Product Portfolio
- 8.11.5 SGD Pharma's Gerresheimer Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst